Inverness Medical spending more money on additional acquisition of Korean Standard Diagnostics shares.
It seems to me that IMA has "money to burn" for acquistions- demonstated by IMA purchases in the last two years.
Why not BOCX? (IMA investment in BOCX is minor compared to the money thrown around on other companies; certainly confusing - especially in light of the IMA/BOCX alignment which is a "slam-dunk" according to certain posters)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.